November 8, 2020Open Access

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa

Key Points

Key points are not available for this paper at this time.

Abstract

The low incidences of SARS-CoV-2 infection and disease in SSA appear to be correlated with the pre-pandemic serological cross-recognition of HCoVs, which are substantially more prevalent in SSA than the USA.

Bookmark

View Full Paper

Cite This Study

Tso et al. (Sun,) studied this question.

synapsesocial.com/papers/69dbfc0c9e12f2ae65684095 https://doi.org/https://doi.org/10.1016/j.ijid.2020.10.104

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses2020 · 250 citations
2A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma2016 · 61 citations
3Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans2020 · 1,285 citations
4An Outbreak of Human Coronavirus OC43 Infection and Serological Cross‐Reactivity with SARS Coronavirus2006 · 172 citations
5Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding2020 · 12,575 citations

Bookmark

View Full Paper